21
Bagala, Rampazzo Liliana, Fioravanti Giulia, Mattiello Leonardo: Spirobifluorene derivatives, their preparation and uses thereof. Covion Organic Semiconductors, Bagala, Rampazzo Liliana, Fioravanti Giulia, Mattiello Leonardo, GERVASI Gemma, February 12, 2004: WO/2004/013080 (15 worldwide citation)

The invention concerns Spirobifluorene derivatives having the general formula (II) and the corresponding, radical anions that can be represented via the general formula (II), in which K, L, M and N, the same or different from each other, are independently: H or A-C=O, with the proviso that it is nev ...


22
Peter Panster, Robert Gradl: Formed, polymeric transition-metal complex catalysts with organosiloxane phenylphosphine ligands. Degussa, Beveridge DeGrandi Weilacher & Young, February 16, 1993: US05187134 (14 worldwide citation)

This invention relates to formed, polymeric complexes of metals of the eighth subgroup of the periodic system with ligands of an organosiloxane copolycondensate optionally cross-linked by means of cross-linking agents containing Si, Ti, Zr and/or Al, in the form of statistical, block or mixed copoly ...


23
Robert W Webb II, Joanne J Bronson, John C Martin: Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives. Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic, Rega Stichting v z w, Max D Hensley, December 29, 1998: US05854228 (14 worldwide citation)

A series of compounds of Formula I which have anti-tumor activity, and are useful in treating viral infections, their compositions and use. ##STR1## In Formula I B is a purine or pyrimidine base; alk.sub.1 alk.sub.2 and alk.sub.3 are chemical bonds or alkylene groups; Q is hydrogen or hydroxyl; and ...


24
Anne Sophie Charvet Faury, Michel Camplo, Jean Louis Kraus: N4-substituted cytosinyl 1,3-oxathiolane nucleoside analogues, and their antiviral activity. Laboratoire Laphal, Bierman Muserlian & Lucas, January 13, 1998: US05708000 (14 worldwide citation)

The present invention pertains to the field of organic chemistry, and particularly therapeutic chemistry. The invention provides cis-form 5-(cytosinyl-1) 1,3-oxathiolanes of general formula (I), wherein R is an acyl or aralkoyl radical, derivatized from a nitrogen monocyclic or bicyclic heterocycle, ...


25
Victor V Nazarov, Elena N Sidorenko: Sulfoderivatives of indanthrone, lyotropic liquid crystal system and anisotropic film on their base. Nitto Denko Corporation, Dorsey & Whitney, November 8, 2005: US06962734 (12 worldwide citation)

The present invention relates to organic chemistry, in particular, to synthesis of sulfoderivatives of the polycyclic compounds and fabrication of optically anisotropic coatings on their base. The indanthrone sulfoderivatives of the general structural formulas I or II capable of forming LLC phase ar ...


26
Brian S Muehl: .alpha.-substituted-3-benzyl-benzofurans. Eli Lilly and Company, Janelle D Strode, Kathleen R S Page, James J Sales, April 22, 1997: US05622974 (12 worldwide citation)

This invention relates to the fields of pharmaceutical and organic chemistry and provides novel 3-benzyl-benzofurans which are .alpha.-substituted with ether, thioether amino, cyano or halo that are useful for the treatment of the various medical indications associated with post-menopausal syndrome, ...


27
Muehl Brian Stephen: Alpha-substituted-1-benzyl-naphthyls. Lilly Co Eli, September 25, 1996: EP0733620-A1 (12 worldwide citation)

This invention relates to the fields of pharmaceutical and organic chemistry and provides novel 1-benzyl-naphthyls (I) which are alpha -substituted with ether, thioether, amino, hydrazino, cyano or halo that are useful for the treatment of the various medical indications associated with post-menopau ...


28
Kuo Long Yu, Joanne J Bronson, John C Martin: Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents. Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic, Rega Stichting v z w, April 12, 1994: US05302585 (11 worldwide citation)

The present invention provides chiral nucleotide analogs having the Formulas I and II ##STR1## and pharmaceutically acceptable salts and solvates thereof, and their pharmaceutical compositions for use in the treatment of viral infections, especially those caused by human immunodeficiency virus (HIV) ...


29

30
Antonin Holy, Ivan Rosenberg, Erik D A De Clercq: N-phosphonylmethoxyalkyl derivatives of pyrimdine and purine bases and a therapeutical composition therefrom with antiviral activity. Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic, Rega Stichting v z w, Max D Hensley, June 24, 1997: US05641763 (10 worldwide citation)

This invention relates to new nucleotide analogues and solves the technical problem of their use as biologically active compounds. The subject of this invention are N-(2-phosphonylmethoxyethyl) and N-(3-hydroxy-2-phosphonylmethoxypropyl) derivatives of pyrimidine and purine bases, easily accessible ...



Click the thumbnails below to visualize the patent trend.